News Releases Letter to Stockholders Regarding Pending Transaction with GHO Capital Partners LLP and Ampersand Capital Partners Dec 9 2010 Peregrine Pharmaceuticals Reports Second Quarter Fiscal Year 2011 Financial Results and Recent Developments Dec 8 2010 Avid Bioservices Secures New Biosimilar Development Project Dec 2 2010 Peregrine to Report Second Quarter Fiscal Year 2011 Financial Results After Market Close on December 9, 2010 Dec 1 2010 Peregrine Announces Initiation of Phase I/II Investigator-Sponsored Trial in Liver Cancer Nov 17 2010 Peregrine's Bavituximab Demonstrates Broad Potential in Viral Hemorrhagic Fever Infection Models Nov 2 2010 Peregrine Awarded $977,917 Grant Under IRS Section 48D for Qualifying Therapeutic Discovery Projects Oct 25 2010 Avid Bioservices to Present at IBC's Preclinical Scale Bioprocessing Conference November 1-3, 2010 Oct 21 2010 Peregrine Appoints Chairman of the Board and Announces Results From Annual Meeting of Stockholders Oct 20 2010 Peregrine to Present Bavituximab Antiviral Data at 2010 Chemical and Biological Defense Science and Technology Conference Oct 18 2010 Peregrine Reports Promising Interim Survival Data From Phase II Cotara(R) Brain Cancer Study Pagination First page « first Previous page ‹ previous … Page 35 Page 36 Page 37 Page 38 Current page 39 Page 40 Page 41 Page 42 Page 43 … Next page next › Last page last »